NCT00289718View on ClinicalTrials.gov

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 1, 2004

Primary Completion Date

March 2, 2005

Study Completion Date

March 2, 2005

Conditions
Hepatitis BHepatitis A
Interventions
BIOLOGICAL

Twinrix™ adult

Intramuscular administration

Trial Locations (1)

9000

GSK Investigational Site, Ghent

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY